The agriflu market has seen considerable growth due to a variety of factors.
• In recent times, the agriflu market has experienced a XX (HCAGR) expansion. The market, which stood at $XX million in 2024, will surge to $XX million in 2025, indicating a compound annual growth rate (CAGR) of XX%.
The upsurge during the historical span can be credited to increased understanding of seasonal influenza vaccination, the surge in the elderly populace, steps taken for preparing for pandemics, enhancements in egg-based vaccine technology, and worldwide partnerships for distribution.
The agriflu market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the agriflu market is projected to witness an XX (FCAGR) rise. It is slated to reach a valuation of $XX million in 2029, growing at a compound annual growth rate (CAGR) of XX%.
Various factors contributing to this increase during the predicted period include the creation of universal flu vaccines, the expansion of immunization schemes in underdeveloped nations, heightened knowledge of influenza risks following the covid-19 pandemic, innovations in the mechanisms of vaccine delivery, attention to pediatric and at-risk groups, as well as collaborations between the public and private sector. The period is anticipated to see significant trends such as advancements in vaccine technology, the creation of next-generation vaccines, novelty in vaccine formulas, and the integration of digital technology into agriculture.
The agriflu market is poised to grow owing to the rising incidences of influenza. Being a contagious respiratory ailment induced by flu viruses, the proliferation of influenza can be attributed to factors such as enhanced global travelling, the virus evolving into different strains, fluctuating seasonal trends, restricted immunity among populace, and inadequate vaccination coverage in certain areas. Agriflu aims at providing focused vaccination for poultry, thereby suppressing the spread of avian flu, minimizing the possibility of the virus being transmitted from birds to humans, and hence proving to be instrumental in managing outbreaks and avert potential public health hazards. For example, as per the World Health Organization based in Switzerland, in October 2023, annually there are approximately one billion occurrences of seasonal influenza, including 3–5 million severe cases, hence making clear the impact of rising influenza cases on the agriflu market growth. The agriflu market is also expected to benefit from government-led initiatives for research and development in healthcare. These government-led measures range from actions, programmes, and policies to projects undertaken by government authorities at different levels including local, regional, national or international to tackle specific issues or attain specific goals and bring about positive societal changes. A lot of these authorities have been initiating numerous healthcare programs, including those supporting agriflu. For instance, £260 million ($270.65 million) was committed by BEIS and DHSC in 2022, according to the UK's Department of Health and Social Care, towards boosting health research and manufacturing. The fund includes £60 million ($63.60 million) targeted towards expanding life sciences manufacturing in the UK. Therefore, the increased government-led initiatives towards research and development in healthcare are propelling the growth of the agriflu market.
The agriflu market covered in this report is segmented –
1) By Clinical Indication: Avian Influenza (Bird Flu), Foot and Mouth Disease (FMD), Classical Swine Fever (CSF), Other Indications
2) By Route Of Administration: Injectable Vaccines, Nasal Spray Vaccines
3) By Distribution Channel: Hospitals And Clinics, Retail And Specialty Pharmacies, Government And Institutional Supply
Major companies operating in the agriflu market include:
• Sanofi Pasteur S.A.
North America was the largest region in the agriflu market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the agriflu market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.